Romano Brothers & Co’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-204
Closed -$8.29K 440
2022
Q4
$8.29K Buy
+204
New +$8.29K ﹤0.01% 755